NASHVILLE, Tenn. / Oct 22, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced it will host its sixth annual “Crush the Crisis” national prescription drug take back day on Saturday, Oct. 26, 2024. This year, 133 HCA Healthcare facilities across the country will partner with local law enforcement to help communities safely and anonymously dispose of unused or expired medications.
Held each year, in alignment with the Drug Enforcement Administration’s (DEA) National Prescription Drug Take Back Day, HCA Healthcare holds “Crush the Crisis” events to raise awareness about the dangers of prescription drug misuse and the importance of proper disposal of unused or expired medications. Last year, more than 120 HCA Healthcare facilities from all 15 U.S. divisions helped to collect 13,136 pounds, equivalent to approximately 9 million doses, of unused and expired prescription medications. Since launching “Crush the Crisis” as an enterprise initiative in 2019, HCA Healthcare has helped collect more than 67,500 pounds of medication.
“Take back events, like ‘Crush the Crisis,’ support the essential work of curbing the nationwide issue of prescription drug misuse,” said Dr. Randy Fagin, chief medical officer of HCA Healthcare’s National Group. “As we go into our sixth year, I am proud of our ongoing work as an organization to support our community needs today and help shape a healthier tomorrow.”
To further help combat the nation’s opioid crisis, HCA Healthcare has worked with the National Academy of Medicine’s (NAM) Action Collaborative on Countering the U.S. Opioid Epidemic. HCA Healthcare uses data from approximately 43 million annual patient encounters to help continuously improve care. The organization uses the science of “big data” to help reduce prescription drug misuse and transform pain management, with initiatives in surgical, emergency and other care settings, including:
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 188 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its more than 43 million annual patient encounters to advance science, improve patient care and save lives.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
Last Trade: | US$303.62 |
Daily Change: | 6.10 2.05 |
Daily Volume: | 2,421,651 |
Market Cap: | US$76.910B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB